| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2017 | Shen K, Wang Q. Copper-Catalyzed Alkene Aminoazidation as a Rapid Entry to 1,2-Diamines and Installation of an Azide Reporter onto Azahetereocycles. Journal of the American Chemical Society. PMID 28825822 DOI: 10.1021/Jacs.7B06852 | 0.308 | |||
| 2017 | Shen K, Han X, Lu X, Hu Z. Cationic Pd(II)-catalyzed arylative cyclization of 1,6-enynes with arylboronic acids Tetrahedron Letters. 58: 3768-3771. DOI: 10.1016/J.Tetlet.2017.08.036 | 0.703 | |||
| 2015 | Shen K, Han X, Xia G, Lu X. Cationic Pd(ii)-catalyzed cyclization of N-tosyl-aniline tethered alkynyl ketones initiated by hydropalladation of alkynes: a facile way to 1,2-dihydro or 1,2,3,4-tetrahydroquinoline derivatives Organic Chemistry Frontiers. 2: 145-149. DOI: 10.1039/C4Qo00286E | 0.534 | |||
| 2014 | Sun S, Fei X, Mao Y, Wang X, Garfield DH, Huang O, Wang J, Yuan F, Sun L, Yu Q, Jin X, Wang J, Shen K. PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients. Cancer Immunology, Immunotherapy : Cii. 63: 395-406. PMID 24514954 DOI: 10.1007/s00262-014-1519-x | 0.396 | |||
| 2013 | Shen K, Han X, Lu X. Cationic Pd(II)-catalyzed reductive cyclization of alkyne-tethered ketones or aldehydes using ethanol as hydrogen source. Organic Letters. 15: 1732-5. PMID 23517106 DOI: 10.1021/Ol400531A | 0.673 | |||
| 2012 | Shen K, Han X, Lu X. Cationic Pd(II)-catalyzed highly enantioselective arylative cyclization of alkyne-tethered enals or enones initiated by carbopalladation of alkynes with arylboronic acids. Organic Letters. 14: 1756-9. PMID 22449236 DOI: 10.1021/Ol3003546 | 0.693 | |||
| Low-probability matches (unlikely to be authored by this person) | |||||
| 2015 | Shen K, Wang Q. Copper-catalyzed diamination of unactivated alkenes with hydroxylamines. Chemical Science. 6: 4279-4283. PMID 29218196 DOI: 10.1039/C5Sc00897B | 0.233 | |||
| 2017 | Shen K, Wang Q. Copper-catalyzed aminoalkynylation of alkenes with hypervalent iodine reagents. Chemical Science. 8: 8265-8270. PMID 29568474 DOI: 10.1039/C7Sc03420B | 0.223 | |||
| 2021 | Montagna G, Tong Y, Ritter M, Levi J, Weber WP, Chen X, Shen K. Predictors of Nodal Pathological Complete Response in Asian Women with Stage II-III Node-Positive Breast Cancer. Oncology. 1-6. PMID 33735903 DOI: 10.1159/000513454 | 0.207 | |||
| 2009 | Chen X, Chen C, Wu J, Wu J, Lu J, Shao Z, Shen Z, Shen K. 0180 Weekly paclitaxel plus carboplatin +/− trastuzumab in preoperative therapy of Her2-neu over-expressing breast cancer: A pilot phase II study The Breast. 18: S63-S64. DOI: 10.1016/S0960-9776(09)70203-6 | 0.204 | |||
| 2016 | Hemric BN, Shen K, Wang Q. Copper-Catalyzed Amino Lactonization and Amino Oxygenation of Alkenes Using O-Benzoylhydroxylamines. Journal of the American Chemical Society. PMID 27114046 DOI: 10.1021/Jacs.6B02840 | 0.187 | |||
| 2019 | Huang C, Yang Y, Kwong A, Chen S, Tseng L, Liu M, Shen K, Wang S, Ng T, Feng Y, Sun G, Yan I, Shao Z. Trastuzumab emtansine (T-DM1) vs trastuzumab (H) in Chinese patients (pts) with residual invasive disease after neoadjuvant chemotherapy for HER2-positive breast cancer (BC) in the phase III KATHERINE study Annals of Oncology. 30: ix1. DOI: 10.1093/annonc/mdz416 | 0.159 | |||
| 2006 | Fan J, Wang L, Wang XJ, Wu J, Lu JS, Di GH, Shen KW, Han QX, Liu BL, Shen ZZ, Shao ZM. Breast conservative therapy in east part of China: a retrospective cohort study. Journal of Cancer Research and Clinical Oncology. 132: 573-8. PMID 16741727 DOI: 10.1007/s00432-006-0104-x | 0.158 | |||
| 2021 | Hong J, Tong Y, He J, Chen X, Shen K. Association between tumor molecular subtype, clinical stage and axillary pathological response in breast cancer patients undergoing complete pathological remission after neoadjuvant chemotherapy: potential implications for de-escalation of axillary surgery. Therapeutic Advances in Medical Oncology. 13: 1758835921996673. PMID 33737963 DOI: 10.1177/1758835921996673 | 0.156 | |||
| 2023 | Shen K, Yu H, Xie B, Meng Q, Dong C, Shen K, Zhou HB. Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression. Pharmacology & Therapeutics. 242: 108350. PMID 36690079 DOI: 10.1016/j.pharmthera.2023.108350 | 0.153 | |||
| 2020 | Xu B, Hu X, Feng J, Geng C, Jin F, Li H, Li M, Li Q, Liao N, Liu D, Liu J, Liu Q, Lu J, Liu Z, Ma F, ... ... Shen K, et al. Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018). Cancer. 126: 3867-3882. PMID 32710660 DOI: 10.1002/cncr.32832 | 0.153 | |||
| 2020 | Fang Y, Wang Z, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. Factors Influencing Adjuvant Chemotherapy and Trastuzumab Choice in Older Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Patients. Journal of Cancer. 11: 2602-2609. PMID 32201530 DOI: 10.7150/jca.39509 | 0.152 | |||
| 2018 | Cao L, Xu C, Kirova YM, Cai G, Cai R, Wang SB, Shen KW, Ou D, Chen JY. The Role of the Neo-Bioscore Staging System in Guiding the Optimal Strategies for Regional Nodal Irradiation Following Neoadjuvant Treatment in Breast Cancer Patients with cN1 and ypN0-1. Annals of Surgical Oncology. PMID 30519764 DOI: 10.1245/s10434-018-07095-9 | 0.152 | |||
| 2016 | Harbeck N, Huang CS, Hurvitz S, Yeh DC, Shao Z, Im SA, Jung KH, Shen K, Ro J, Jassem J, Zhang Q, Im YH, Wojtukiewicz M, Sun Q, Chen SC, et al. Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial. The Lancet. Oncology. PMID 26822398 DOI: 10.1016/S1470-2045(15)00540-9 | 0.152 | |||
| 2018 | Qu F, Chen X, Fei X, Lin L, Gao W, Zong Y, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Shen K. A nomogram to predict adjuvant chemotherapy recommendation in breast cancer patients with intermediate recurrence score. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 30: 222-230. PMID 29861607 DOI: 10.21147/j.issn.1000-9604.2018.02.05 | 0.15 | |||
| 2016 | Huang O, Wu D, Zhu L, Li Y, Chen W, Shen K. Concurrent adjuvant radiochemotherapy versus standard chemotherapy followed by radiotherapy in operable breast cancer after breast conserving therapy: A meta-analysis. Journal of Cancer Research and Therapeutics. 12: 84-9. PMID 27072216 DOI: 10.4103/0973-1482.148702 | 0.149 | |||
| 2014 | André F, O'Regan R, Ozguroglu M, Toi M, Xu B, Jerusalem G, Masuda N, Wilks S, Arena F, Isaacs C, Yap YS, Papai Z, Lang I, Armstrong A, Lerzo G, ... ... Shen K, et al. Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. Oncology. 15: 580-91. PMID 24742739 DOI: 10.1016/S1470-2045(14)70138-X | 0.148 | |||
| 2009 | Ma C, Shen Z, Shao Z, Shen K. 0067 Factors influencing postoperative chemotherapy of elderly breast cancer patients The Breast. 18: S35. DOI: 10.1016/S0960-9776(09)70112-2 | 0.148 | |||
| 2018 | Cao L, Ou D, Shen KW, Cai G, Cai R, Xu F, Zhao SG, Xu C, Grellier Adedjouma N, Kirova YM, Chen JY. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer. Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique. PMID 29306555 DOI: 10.1016/j.canrad.2017.07.051 | 0.147 | |||
| 2021 | Xu B, Yan M, Ma F, Hu X, Feng J, Ouyang Q, Tong Z, Li H, Zhang Q, Sun T, Wang X, Yin Y, Cheng Y, Li W, Gu Y, ... ... Shen K, et al. Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial. The Lancet. Oncology. PMID 33581774 DOI: 10.1016/S1470-2045(20)30702-6 | 0.147 | |||
| 2019 | Hong J, Chen X, Gao W, Zhu S, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Fei X, Lin L, Shen K. A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumab. Cancer Management and Research. 11: 3371-3379. PMID 31114373 DOI: 10.2147/CMAR.S187233 | 0.147 | |||
| 2016 | Chen X, Ye G, Zhang C, Li X, Shen K. Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 28: 561-569. PMID 28174484 DOI: 10.21147/j.issn.1000-9604.2016.06.02 | 0.146 | |||
| 2014 | Qu Q, Mao Y, Zhang Y, Liu J, Chen X, Shen K. USP2 Promotes Progression in Triple Negative Breast Cancer Annals of Oncology. 25: i8. DOI: 10.1093/ANNONC/MDU066.16 | 0.146 | |||
| 2020 | Hong J, Huang J, Shen L, Zhu S, Gao W, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis. Bmc Cancer. 20: 663. PMID 32677982 DOI: 10.1186/s12885-020-07156-x | 0.146 | |||
| 2013 | Zhang X, Mu X, Huang O, Xie Z, Jiang M, Geng M, Shen K. Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling. Plos One. 8: e72053. PMID 23991038 DOI: 10.1371/journal.pone.0072053 | 0.145 | |||
| 2010 | Chen XS, Nie XQ, Chen CM, Wu JY, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW. Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 961-7. PMID 20211870 DOI: 10.1093/annonc/mdq041 | 0.144 | |||
| 2013 | Zong Y, Zhu L, Wu J, Chen X, Huang O, Fei X, He J, Chen W, Li Y, Shen K. Abstract P6-06-57: Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P6-06-57 | 0.144 | |||
| 2003 | Li HC, Wen XF, Hou YF, Shen KW, Wu J, Lu JS, Shen ZZ, Shao ZM. Addition of adjuvant tamoxifen to cyclophosphamide, methotrexate and 5-fluorouracil for premenopausal women with oestrogen receptor-positive breast cancer. Asian Journal of Surgery / Asian Surgical Association. 26: 163-8. PMID 12925292 DOI: 10.1016/S1015-9584(09)60377-8 | 0.144 | |||
| 2018 | Lu S, Wu J, Fang Y, Wang W, Zong Y, Chen X, Huang O, He JR, Chen W, Li Y, Shen K, Zhu L. The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis. Oncotarget. 9: 11816-11823. PMID 29545938 DOI: 10.18632/Oncotarget.23189 | 0.144 | |||
| 2013 | Chen X, Ye G, Zhang C, Li X, Chen Y, Xie X, Zheng H, Cao Y, Wu K, Ni D, Tang J, Wei Z, Shen K. Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer. Breast Cancer Research and Treatment. PMID 24234000 DOI: 10.1007/s10549-013-2761-1 | 0.144 | |||
| 2009 | Lin Y, Yin W, Zhou L, Yan T, Lu J, Di G, Wu J, Shen K, Shao Z. Postsurgical drainage and the risk of breast cancer recurrence in Chinese breast cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e22234. PMID 27964111 DOI: 10.1200/jco.2009.27.15_suppl.e22234 | 0.144 | |||
| 2020 | Cao L, Xu C, Cai G, Qi WX, Cai R, Wang SB, Ou D, Li M, Shen KW, Chen JY. How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients? Annals of Surgical Oncology. PMID 32974696 DOI: 10.1245/s10434-020-09026-z | 0.142 | |||
| 2017 | Colell JFP, Emondts M, Logan AWJ, Shen K, Bae J, Shchepin RV, Ortiz GX, Spannring P, Wang Q, Malcolmson SJ, Chekmenev EY, Feiters MC, Rutjes FPJT, Bluemich B, Theis T, et al. Direct Hyperpolarization of Nitrogen-15 in Aqueous Media with Parahydrogen in Reversible Exchange. Journal of the American Chemical Society. PMID 28443329 DOI: 10.1021/Jacs.7B00569 | 0.142 | |||
| 2010 | Yuan Y, Chen XS, Liu SY, Shen KW. Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis. Ajr. American Journal of Roentgenology. 195: 260-8. PMID 20566826 DOI: 10.2214/AJR.09.3908 | 0.142 | |||
| 2009 | Huang O, Chen C, Wu J, Chen S, Chen X, Liu G, Hu Z, Lu J, Wu J, Shao Z, Shen Z, Shen K. Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months. Bmc Cancer. 9: 375. PMID 19845944 DOI: 10.1186/1471-2407-9-375 | 0.141 | |||
| 2015 | Qu Q, Mao Y, Xiao G, Fei X, Wang J, Zhang Y, Liu J, Cheng G, Chen X, Wang J, Shen K. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 25687182 DOI: 10.1007/s13277-015-3207-7 | 0.14 | |||
| 2009 | Yin W, Lu J, Di G, Lin Y, Zhou L, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. 0147 Demographic features and prognostic profiles of adjuvant chemotherapy regimens in Chinese breast cancer patients The Breast. 18: S56. DOI: 10.1016/S0960-9776(09)70178-X | 0.14 | |||
| 2010 | Chen X, Wu J, Shen K, Lu H, Lu J, Wu J, Shao Z, Shen Z. 104 Molecular biomarkers to predict neoadjuvant chemotherapy response in breast cancer patients treated with weekly paclitaxel plus carboplatin European Journal of Cancer Supplements. 8: 88-89. DOI: 10.1016/S1359-6349(10)70135-X | 0.14 | |||
| 2009 | Liu Z, Wu J, Ping B, Feng L, Di G, Lu J, Shen K, Shen Z, Shao Z. Basal Cytokeratin Expression in Relation to Immunohistochemical and Clinical Characterization in Breast Cancer Patients with Triple Negative Phenotype Tumori Journal. 95: 53-62. DOI: 10.1177/030089160909500110 | 0.14 | |||
| 2019 | Gao W, Wu J, Chen X, Lin L, Fei X, Shen K, Huang O. Clinical validation of Ki67 by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in HR+/HER2- early breast cancer. Journal of Cancer. 10: 1110-1116. PMID 30854118 DOI: 10.7150/jca.29337 | 0.139 | |||
| 2014 | Wu J, Zong Y, Fei X, Chen X, Huang O, He J, Chen W, Li Y, Shen K, Zhu L. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer. Plos One. 9: e98673. PMID 25153161 DOI: 10.1371/journal.pone.0098673 | 0.139 | |||
| 2021 | Ding S, Sun X, Lu S, Wang Z, Chen X, Shen K. Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer. Breast (Edinburgh, Scotland). 57: 71-79. PMID 33774461 DOI: 10.1016/j.breast.2021.03.005 | 0.139 | |||
| 2009 | Chen X, Chen C, Wu J, Yang W, Nie X, Di G, Wu J, Lu J, Shao Z, Shen Z, Shen K. 0179 Weekly paclitaxel and carboplatin is an effective non-anthracycline regimen in preoperative therapy of breast cancer The Breast. 18: S63. DOI: 10.1016/S0960-9776(09)70202-4 | 0.139 | |||
| 2012 | Tang Y, Zhu L, Li Y, Ji J, Li J, Yuan F, Wang D, Chen W, Huang O, Chen X, Wu J, Shen K, Loo WT, Chow LW. Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer. Journal of Translational Medicine. 10: S4. PMID 23046633 DOI: 10.1186/1479-5876-10-S1-S4 | 0.138 | |||
| 2017 | Toi M, Shao Z, Hurvitz S, Tseng LM, Zhang Q, Shen K, Liu D, Feng J, Xu B, Wang X, Lee KS, Ng TY, Ridolfi A, Noel-Baron F, Ringeisen F, et al. Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1. Breast Cancer Research : Bcr. 19: 47. PMID 28399902 DOI: 10.1186/s13058-017-0839-0 | 0.138 | |||
| 2019 | Wang G, Qin S, Zayas J, Ingle JN, Liu M, Weinshilboum R, Shen K, Wang L. Abstract 2940: 4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen andZNF423SNP-dependent fashion Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2940 | 0.138 | |||
| 2014 | Mao Y, Chen X, Gao W, Liu J, Shen K. [Treatment patterns and affecting factors in breast cancer patients over 65-years of age]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 36: 366-71. PMID 25030593 DOI: 10.3760/cma.j.issn.0253-3766.2014.05.010 | 0.138 | |||
| 2014 | Mao Y, Qu Q, Chen X, Zhang Y, Liu J, Wang G, Xiao G, Wang X, Shen K. Effect of cancer-associated fibroblasts on trastuzumab resistance by activating multiple pathways in HER2-positive breast cancer. Journal of Clinical Oncology. 32: e11587-e11587. DOI: 10.1200/jco.2014.32.15_suppl.e11587 | 0.138 | |||
| 2015 | Hurvitz SA, Andre F, Jiang Z, Shao Z, Mano MS, Neciosup SP, Tseng LM, Zhang Q, Shen K, Liu D, Dreosti LM, Burris HA, Toi M, Buyse ME, Cabaribere D, et al. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial. The Lancet. Oncology. 16: 816-29. PMID 26092818 DOI: 10.1016/S1470-2045(15)00051-0 | 0.137 | |||
| 2015 | Mao Y, Zhang Y, Qu Q, Zhao M, Lou Y, Liu J, huang O, Chen X, Wu J, Shen K. Cancer-associated fibroblasts induce trastuzumab resistance in HER2 positive breast cancer cells. Molecular Biosystems. 11: 1029-40. PMID 25648538 DOI: 10.1039/c4mb00710g | 0.137 | |||
| 2014 | Zong Y, Zhu L, Wu J, Chen X, Huang O, Fei X, He J, Chen W, Li Y, Shen K. Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective study. Plos One. 9: e95629. PMID 25170613 DOI: 10.1371/journal.pone.0095629 | 0.137 | |||
| 2011 | Wei M, Zhu L, Li Y, Chen W, Han B, Wang Z, He J, Yao H, Yang Z, Zhang Q, Liu B, Gu Q, Zhu Z, Shen K. Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model. Cancer Science. 102: 1537-44. PMID 21521417 DOI: 10.1111/j.1349-7006.2011.01969.x | 0.136 | |||
| 2015 | Mao Y, Qu Q, Zhang Y, Liu J, Shen K. P005 Cancer-associated fibroblasts induce trastuzumab resistances in HER2-positive breast cancer The Breast. 24: S27. DOI: 10.1016/S0960-9776(15)70056-1 | 0.136 | |||
| 2019 | Cao L, Kirova Y, Shen K, Xu C, Chen J. Clinical Impact of Delaying Initiation of Radiotherapy after Definitive Surgery or Adjuvant Chemotherapy in Breast Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 105: E1. DOI: 10.1016/j.ijrobp.2019.06.618 | 0.136 | |||
| 2018 | Ding S, Wu J, Lin C, Chen W, Li Y, Shen K, Zhu L. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis. Clinical Breast Cancer. PMID 30396812 DOI: 10.1016/j.clbc.2018.10.001 | 0.135 | |||
| 2017 | Chen XS, Shen KW. [Multi-gene assay profiling testing and individualized therapy in breast cancer]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 55: 99-103. PMID 28162207 DOI: 10.3760/cma.j.issn.0529-5815.2017.02.005 | 0.135 | |||
| 2014 | Wu JY, Chen WG, Chen XS, Huang O, He JR, Zhu L, Li Y, Shen KW, Chow LW, Loo WT, Chow CY, Tsang W. Outcomes of adjuvant endocrine therapy and hormone receptor status change following neoadjuvant chemotherapy in breast cancer patients. The International Journal of Biological Markers. 29: e380-6. PMID 25385240 DOI: 10.5301/jbm.5000113 | 0.135 | |||
| 2014 | Liu J, Chen X, Mao Y, Qu Q, Shen K. Association of epithelial-mesenchymal transition with lapatinib resistance through multipe pathways activation in HER2-positive breast cancer. Journal of Clinical Oncology. 32: e11579-e11579. DOI: 10.1200/JCO.2014.32.15_SUPPL.E11579 | 0.135 | |||
| 2010 | Ma C, Niu X, Luo J, Shao Z, Shen K. Combined effects of lapatinib and bortezomib in human epidermal receptor 2 (HER2)-overexpressing breast cancer cells and activity of bortezomib against lapatinib-resistant breast cancer cells. Cancer Science. 101: 2220-6. PMID 20701607 DOI: 10.1111/j.1349-7006.2010.01662.x | 0.135 | |||
| 2009 | Yin W, Di G, Liu G, Wu J, Lu J, Shen K, Han Q, Shen Z, Shao Z. Demographic features and prognostic profiles of breast cancer patients presenting with nipple discharge in Chinese population. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e22204. PMID 27964133 DOI: 10.1200/jco.2009.27.15_suppl.e22204 | 0.134 | |||
| 2020 | Liu D, Wu J, Lin C, Andriani L, Ding S, Shen K, Zhu L. Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study. Frontiers in Oncology. 10: 580112. PMID 33344236 DOI: 10.3389/fonc.2020.580112 | 0.134 | |||
| 2010 | Chen W, Jiang Z, Shao Z, Sun Q, Shen K. An economic evaluation of adjuvant trastuzumab therapy in HER2-positive early breast cancer. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. S82-4. PMID 20586989 DOI: 10.1111/j.1524-4733.2009.00634.x | 0.134 | |||
| 2018 | Wang W, Chen X, Lin L, Fei X, Garfield DH, Hong J, Gao W, Zhu S, Wu J, Huang O, He J, Li Y, Zhu L, Chen W, Shen K. Distribution and Clinical Utility of the 21-gene Recurrence Score in Pure Mucinous Breast Cancer Patients: a case-control study. Journal of Cancer. 9: 3216-3224. PMID 30271480 DOI: 10.7150/Jca.27291 | 0.134 | |||
| 2021 | Zhu S, Li Y, Chen W, Fei X, Shen K, Chen X. Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment. Frontiers in Oncology. 11: 636266. PMID 33680973 DOI: 10.3389/fonc.2021.636266 | 0.134 | |||
| 2012 | Chen X, Wu J, Lu H, Huang O, Shen K. Measuring β-tubulin III, Bcl-2, and ERCC1 improves pathological complete remission predictive accuracy in breast cancer. Cancer Science. 103: 262-8. PMID 22035021 DOI: 10.1111/j.1349-7006.2011.02135.x | 0.132 | |||
| 2020 | Tong Y, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. IGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive Breast Cancer Patients. Frontiers in Oncology. 10: 550. PMID 32391265 DOI: 10.3389/fonc.2020.00550 | 0.132 | |||
| 2020 | Wang Z, Wang H, Ding X, Chen X, Shen K. A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer. Therapeutic Advances in Medical Oncology. 12: 1758835920932674. PMID 32550867 DOI: 10.1177/1758835920932674 | 0.132 | |||
| 2007 | Yu KD, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data. Annals of Surgical Oncology. 14: 2502-9. PMID 17564750 DOI: 10.1245/s10434-007-9436-2 | 0.132 | |||
| 2009 | Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Time-varying pattern of recurrence risk for Chinese breast cancer patients. Breast Cancer Research and Treatment. 114: 527-35. PMID 18425576 DOI: 10.1007/s10549-008-0022-5 | 0.132 | |||
| 2017 | Hong J, Chen X, Huang J, Li C, Zhong L, Chen L, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Wan H, Shen K. Danggui Buxue Decoction, a Classical Formula of Traditional Chinese Medicine, Fails to Prevent Myelosuppression in Breast Cancer Patients Treated With Adjuvant Chemotherapy: A Prospective Study. Integrative Cancer Therapies. 16: 406-413. PMID 28818031 DOI: 10.1177/1534735416675952 | 0.131 | |||
| 2000 | Zhang Y, Shen Z, Han Q, Shen K, Xiang J, Zhang T. Ductal carcinomain situ of the breast Chinese Journal of Cancer Research. 12: 290-292. DOI: 10.1007/BF02983509 | 0.131 | |||
| 2005 | Fan J, Wu J, Lu J, Wang L, Hou Y, Wang J, Di G, Shen K, Han Q, Liu B, Shen Z, Shao Z. Breast conserving therapy in stage T1 & T2 breast cancer patients Chinese Journal of Cancer Research. 17: 137-139. DOI: 10.1007/S11670-005-0059-5 | 0.13 | |||
| 2020 | Li S, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab. Breast (Edinburgh, Scotland). 54: 235-241. PMID 33166784 DOI: 10.1016/j.breast.2020.10.002 | 0.13 | |||
| 2019 | Ding S, Wu J, Lin C, Andriani L, Goh C, Chen W, Li Y, Shen K, Zhu L. Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis. The Oncologist. PMID 31019021 DOI: 10.1634/theoncologist.2018-0727 | 0.13 | |||
| 2021 | Sun X, Zhou ZR, Fang Y, Ding S, Lu S, Wang Z, Wang H, Chen X, Shen K. A novel metabolic gene signature-based nomogram to predict overall survival in breast cancer. Annals of Translational Medicine. 9: 367. PMID 33842588 DOI: 10.21037/atm-20-4813 | 0.129 | |||
| 2001 | Shen KW, Wu J, Lu JS, Han QX, Shen ZZ, Nguyen M, Barsky SH, Shao ZM. Fiberoptic ductoscopy for breast cancer patients with nipple discharge. Surgical Endoscopy. 15: 1340-5. PMID 11727147 DOI: 10.1007/s004640080108 | 0.129 | |||
| 2020 | Yu J, Wu J, Huang O, He J, Li Z, Chen W, Li Y, Chen X, Shen K. Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients? Frontiers in Oncology. 10: 708. PMID 32477946 DOI: 10.3389/fonc.2020.00708 | 0.129 | |||
| 2015 | Xu B, Hu X, Jiang Z, Li H, Chen J, Cui S, Li Q, Liao N, Liu D, Liu J, Lu J, Shen K, Sun T, Teng Y, Tong Z, et al. National consensus in China on diagnosis and treatment of patients with advanced breast cancer. Annals of Translational Medicine. 3: 242. PMID 26605288 DOI: 10.3978/j.issn.2305-5839.2015.09.47 | 0.129 | |||
| 2015 | Mao Y, Qu Q, Wu J, Chen X, Huang O, Shen K. P222 Tumor-infiltrating lymphocytes predict prognosis in early breast cancer The Breast. 24: S101. DOI: 10.1016/S0960-9776(15)70254-7 | 0.129 | |||
| 2018 | Wang G, Chen X, Liang Y, Wang W, Fang Y, Shen K. Long Noncoding RNA Signature and Disease Outcome in Estrogen Receptor-Positive Breast Cancer Patients Treated with Tamoxifen. Journal of Breast Cancer. 21: 277-287. PMID 30275856 DOI: 10.4048/Jbc.2018.21.E39 | 0.129 | |||
| 2008 | Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, et al. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Research and Treatment. 110: 99-109. PMID 17851763 DOI: 10.1007/s10549-007-9708-3 | 0.128 | |||
| 2019 | Lin C, Wu J, Ding S, Goh C, Andriani L, Shen K, Zhu L. Impact of Prior Cancer History on the Clinical Outcomes in Advanced Breast Cancer: A Propensity Score-Adjusted, Population-Based Study. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 31801318 DOI: 10.4143/crt.2019.210 | 0.128 | |||
| 2016 | Liu J, Chen X, Ward T, Pegram M, Shen K. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26810188 DOI: 10.1007/s13277-015-4650-1 | 0.128 | |||
| 2013 | Qu Q, Mao Y, Fei XC, Shen KW. The impact of androgen receptor expression on breast cancer survival: a retrospective study and meta-analysis. Plos One. 8: e82650. PMID 24324816 DOI: 10.1371/journal.pone.0082650 | 0.128 | |||
| 2020 | Gao L, Shen K, Yin N, Jiang M. Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer Cells. Frontiers in Oncology. 10: 600487. PMID 33324567 DOI: 10.3389/fonc.2020.600487 | 0.128 | |||
| 2017 | Wu YD, Liu XH, Xu J, Zhang SH, Shen K, Sun L, He YM, Ma Y, Zhang AH. Crystal structure of an apremilast ethanol hemisolvate hemihydrate solvatomorph. Acta Crystallographica. Section E, Crystallographic Communications. 73: 821-824. PMID 28638635 DOI: 10.1107/S2056989017006661 | 0.127 | |||
| 2016 | Wang W, Wu J, Zhang P, Fei X, Zong Y, Chen X, Huang O, He JR, Chen W, Li Y, Shen K, Zhu L. Prognostic and predictive value of Ki-67 in triple-negative breast cancer. Oncotarget. PMID 27145269 DOI: 10.18632/Oncotarget.9075 | 0.127 | |||
| 2015 | Liu J, Chen X, Mao Y, Shen K. Effect of curcumin on lapatinib sensitivity and lapatinib resistance associated EMT and stem-like phenotype in HER2 positive breast cancer. Journal of Clinical Oncology. 33: e11594-e11594. DOI: 10.1200/JCO.2015.33.15_SUPPL.E11594 | 0.127 | |||
| 2015 | Sun K, Chen X, Chai W, Fei X, Fu C, Yan X, Zhan Y, Chen K, Shen K, Yan F. Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors. Radiology. 141625. PMID 25938679 DOI: 10.1148/radiol.15141625 | 0.127 | |||
| 2013 | Chen X, Zhao M, Hao M, Sun X, Wang J, Mao Y, Zu L, Liu J, Shen Y, Wang J, Shen K. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer. Molecular Cancer Research : McR. 11: 1269-78. PMID 23814023 DOI: 10.1158/1541-7786.MCR-13-0212 | 0.126 | |||
| 2015 | Hong J, Mao Y, Chen X, Zhu L, He J, Chen W, Li Y, Lin L, Fei X, Shen K. Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26490984 DOI: 10.1007/s13277-015-4233-1 | 0.126 | |||
| 2016 | Liang Y, Chen XS, Wu JY, Huang O, Zong Y, Nie LJ, Fang Q, He JR, Zhu L, Chen WG, Li YF, Shen KW. [Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 38: 357-362. PMID 27188608 DOI: 10.3760/cma.j.issn.0253-3766.2016.05.007 | 0.125 | |||
| 2009 | Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, Liu GY, Wu J, Shen KW, Han QX, Shen ZZ, Shao ZM. Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Research and Treatment. 115: 325-33. PMID 18563552 DOI: 10.1007/s10549-008-0096-0 | 0.125 | |||
| 2013 | Chen X, Ye G, Zhang C, Li X, Chen Y, Xie X, Zheng H, Cao Y, Wu K, Ni D, Tang J, Wei Z, Shen K. Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer. Breast Cancer Research and Treatment. 142: 549-58. PMID 24292815 DOI: 10.1007/s10549-013-2790-9 | 0.125 | |||
| 2008 | Huang O, Wang L, Shen K, Lin H, Hu Z, Liu G, Wu J, Lu J, Shao Z, Han Q, Shen Z. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Research and Treatment. 107: 379-87. PMID 17457670 DOI: 10.1007/s10549-007-9561-4 | 0.125 | |||
| 2017 | Zong Y, Wu J, Shen K. Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a meta-analysis The Breast. 32: S83-S84. DOI: 10.1016/S0960-9776(17)30272-2 | 0.125 | |||
| 2000 | Shen KW, Wu J, Lu JS, Han QX, Shen ZZ, Nguyen M, Shao ZM, Barsky SH. Fiberoptic ductoscopy for patients with nipple discharge. Cancer. 89: 1512-9. PMID 11013365 DOI: 10.1002/1097-0142(20001001)89:7<1512::AID-CNCR14>3.0.CO;2-L | 0.125 | |||
| 2017 | Cao L, Kirova M, Xu C, Shen K, Chen J. EP-1410: Role of PMRT in Elderly Patients with T1-2 and 1 to 3 Positive Nodes Breast Cancer Radiotherapy and Oncology. 123: S754. DOI: 10.1016/S0167-8140(17)31845-5 | 0.124 | |||
| 2012 | Shen K, Zhao M, Chen X, Sun X, Wang J. 294 Combining Everolimus with a PI3K Inhibitor Mitigate Cross-Talk and Improves Response to Endocrine Therapy in a Pre-Clinical Breast Cancer Model European Journal of Cancer. 48: S128. DOI: 10.1016/S0959-8049(12)70360-X | 0.124 | |||
| 2013 | Zhang X, Jiang M, Huang O, Xie Z, shen K. Elevated Expression of ZNF703 Confers to Tamoxifen Resistance in Breast Cancer Annals of Oncology. 24: iii46. DOI: 10.1093/ANNONC/MDT087.2 | 0.124 | |||
| 2019 | Fang Q, Huang J, Gan L, Shen K, Chen X, Wu B. Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer. Journal of Breast Cancer. 22: 399-411. PMID 31598340 DOI: 10.4048/jbc.2019.22.e37 | 0.124 | |||
| 2013 | Chen X, Sun L, Mao Y, Zhu S, Wu J, Huang O, Li Y, Chen W, Wang J, Yuan Y, Fei X, Jin X, Shen K. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer. Bmc Cancer. 13: 390. PMID 23957561 DOI: 10.1186/1471-2407-13-390 | 0.124 | |||
| 2021 | Huang CS, Yang Y, Kwong A, Chen SC, Tseng LM, Liu MC, Shen K, Wang S, Ng TY, Feng Y, Sun G, Yan IR, Shao Z. Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study. Breast Cancer Research and Treatment. PMID 33860389 DOI: 10.1007/s10549-021-06166-y | 0.124 | |||
| 2019 | Ding SN, Wu JY, Chen WG, Li YF, Shen KW, Zhu L. [The predicting value of the 8th edition of American Joint Committee on Cancer staging manual in mucinous breast cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 41: 854-858. PMID 31770854 DOI: 10.3760/cma.j.issn.0253-3766.2019.11.010 | 0.124 | |||
| 2022 | Xie J, Xu F, Zhao Y, Cai G, Lin X, Zhu Q, Lin Q, Yao Y, Xu C, Cai R, Wang S, Tang X, Chen C, Zheng S, Chen M, ... ... Shen KW, et al. Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial. Bmj Open. 12: e062034. PMID 36581983 DOI: 10.1136/bmjopen-2022-062034 | 0.123 | |||
| 2016 | Xu BH, Tian FG, Yu JR, Song YQ, Shi JH, Zhang BB, Zhang YJ, Yuan ZP, Wu Q, Zhang QY, Nan KJ, Sun Q, Li WL, Hu JB, Bi JW, ... ... Shen KW, et al. [A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 38: 23-7. PMID 26796802 DOI: 10.3760/cma.j.issn.0253-3766.2016.01.005 | 0.123 | |||
| 2019 | Lin C, Wu J, Ding S, Goh C, Andriani L, Lu S, Shen K, Zhu L. Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 1521-1528. PMID 31805535 DOI: 10.6004/jnccn.2019.7332 | 0.123 | |||
| 2010 | Chen XS, Wu JY, Huang O, Chen CM, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW. Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy. Oncology Reports. 23: 1213-20. PMID 20372832 DOI: 10.3892/or-00000752 | 0.123 | |||
| 2020 | Wang Z, Li TE, Chen M, Pan JJ, Shen KW. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway. Aging. 12. PMID 31986487 DOI: 10.18632/aging.102719 | 0.122 | |||
| 2020 | Wang H, Yao J, Zhu Y, Zhan W, Chen X, Shen K. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes. Cancer Medicine. PMID 32657039 DOI: 10.1002/cam4.3305 | 0.122 | |||
| 2009 | Wu JY, Chen CM, Zhang JX, Hou YF, Hu Z, Liu GY, Di GH, Wu J, Lu JS, Shen KW, Shao ZM, Shen ZZ. [Effect of postoperative pregnancy upon prognosis of young breast cancer patients]. Zhonghua Yi Xue Za Zhi. 89: 3126-9. PMID 20193275 | 0.122 | |||
| 2013 | Huang O, Jiang M, Zhang X, Xie Z, Chen X, Wu J, Liu H, Shen K. Grb14 as an independent good prognosis factor for breast cancer patients treated with neoadjuvant chemotherapy. Japanese Journal of Clinical Oncology. 43: 1064-72. PMID 24031083 DOI: 10.1093/jjco/hyt130 | 0.121 | |||
| 2014 | Chen XS, Yuan Y, Garfield DH, Wu JY, Huang O, Shen KW. Both carboplatin and bevacizumab improve pathological complete remission rate in neoadjuvant treatment of triple negative breast cancer: a meta-analysis. Plos One. 9: e108405. PMID 25247558 DOI: 10.1371/journal.pone.0108405 | 0.121 | |||
| 2015 | Zhang Y, Qu Q, Mao Y, Shen K. [Effect of body mass index on disease-free and overall survival in Chinese women with breast cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 37: 395-9. PMID 26463035 DOI: 10.3760/cma.j.issn.0253-3766.2015.05.018 | 0.121 | |||
| 2015 | Chen X, Liu J, Ward T, Liu X, Mao Y, Bockhorn J, Shen K, Pegram M. Abstract 713: Targeting glycolytic pathway with 2-Deoxy-glucose enhances lapatinib sensitivity in HER2-amplified breast cancer Cancer Research. 75: 713-713. DOI: 10.1158/1538-7445.Am2015-713 | 0.121 | |||
| 2020 | Zhu Y, Wang T, Wu J, Huang O, Zhu L, He J, Li Y, Chen W, Chen X, Shen K. Associations Between Circulating Insulin-Like Growth Factor 1 and Mortality in Women With Invasive Breast Cancer. Frontiers in Oncology. 10: 1384. PMID 32974138 DOI: 10.3389/fonc.2020.01384 | 0.121 | |||
| 2019 | Huang J, Chen X, Fei X, Huang O, Wu J, Zhu L, He J, Chen W, Li Y, Shen K. Changes of Tumor Infiltrating Lymphocytes after Core Needle Biopsy and the Prognostic Implications in Early Stage Breast Cancer: A Retrospective Study. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30744321 DOI: 10.4143/crt.2018.504 | 0.12 | |||
| 2020 | Hong J, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. Early response and pathological complete remission in Breast Cancer with different molecular subtypes: a retrospective single center analysis. Journal of Cancer. 11: 6916-6924. PMID 33123282 DOI: 10.7150/jca.46805 | 0.12 | |||
| 2009 | Lin Y, Yin W, Zhou L, Lu J, Di G, Wu J, Shen K, Han Q, Shen Z, Shao Z. 0052 Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients The Breast. 18: S30-S31. DOI: 10.1016/S0960-9776(09)70097-9 | 0.12 | |||
| 2017 | Wang G, Chen X, Liang Y, Wang W, Shen K. A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer. Translational Oncology. 10: 988-997. PMID 29096247 DOI: 10.1016/J.Tranon.2017.09.005 | 0.12 | |||
| 2024 | Cai J, Zhang J, Shi J, Zhao H, Wei Y, Miao X, Shen K, Zhao R, Xiao L, Hou L. Defective UiO-66-NH (Zr) for Simultaneous Adsorption of Phosphate and Pb for Hydrogen Peroxide Purification. Inorganic Chemistry. PMID 38597294 DOI: 10.1021/acs.inorgchem.4c00179 | 0.12 | |||
| 2024 | Liu W, Xing Y, Yan D, Kong W, Shen K. Nickel-catalyzed electrophiles-controlled enantioselective reductive arylative cyclization and enantiospecific reductive alkylative cyclization of 1,6-enynes. Nature Communications. 15: 1787. PMID 38413585 DOI: 10.1038/s41467-024-45617-0 | 0.12 | |||
| 2024 | Wen S, Bu J, Shen K. Dual Nickel- and Photoredox-Catalyzed Asymmetric Reductive Cross-Coupling To Access Chiral Secondary Benzylic Alcohols. The Journal of Organic Chemistry. PMID 38327084 DOI: 10.1021/acs.joc.3c02293 | 0.12 | |||
| 2024 | Yan D, Wen S, Xing Y, Bu J, Shen K. Nickel-Catalyzed Reductive -Arylative Cyclization of Alkynyl Enones with Aryl Halides. The Journal of Organic Chemistry. PMID 38326966 DOI: 10.1021/acs.joc.3c02120 | 0.12 | |||
| 2020 | Gao Y, Chen X, He Q, Gimple RC, Liao Y, Wang L, Wu R, Xie Q, Rich JN, Shen K, Yuan Z. Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin. Proceedings of the National Academy of Sciences of the United States of America. PMID 33318171 DOI: 10.1073/pnas.2005950117 | 0.12 | |||
| 2012 | Chen X, Yuan Y, Gu Z, Shen K. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis. Breast Cancer Research and Treatment. 134: 957-67. PMID 22370627 DOI: 10.1007/s10549-012-1990-z | 0.119 | |||
| 2020 | Yang X, Huang J, Zhu X, Shen K, Zhu J, Chen X. Compliance with multidisciplinary team recommendations and disease outcomes in early breast cancer patients: An analysis of 4501 consecutive patients. Breast (Edinburgh, Scotland). 52: 135-145. PMID 32512360 DOI: 10.1016/j.breast.2020.05.008 | 0.119 | |||
| 2019 | Zeng Y, Gao W, Lin L, Chen X, Shen K. Impact of 21-gene recurrence score testing on adjuvant chemotherapy decision making in older patients with breast cancer. Journal of Geriatric Oncology. PMID 31704037 DOI: 10.1016/j.jgo.2019.10.006 | 0.119 | |||
| 2007 | Lin Y, Guo XM, Shen KW, Wang JL, Jiang GL. Primary breast lymphoma: long-term treatment outcome and prognosis. Leukemia & Lymphoma. 47: 2102-9. PMID 17071483 DOI: 10.1080/10428190600679064 | 0.119 | |||
| 2019 | Chen XS, Shen KW. [Strategies of surgical and comprehensive management of breast cancer patients with local regional recurrence]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 57: 92-96. PMID 30704210 DOI: 10.3760/cma.j.issn.0529-5815.2019.02.004 | 0.117 | |||
| 2020 | Cai L, Tong Y, Zhu X, Shen K, Zhu J, Chen X. Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients. Scientific Reports. 10: 7029. PMID 32341397 DOI: 10.1038/s41598-020-64005-4 | 0.117 | |||
| 2014 | Huang O, Jiang M, Zhang X, Chen X, Wu J, Shen K. FASLG T844C polymorphism and susceptibility to breast cancer: a meta-analysis. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 1089-94. PMID 24408012 DOI: 10.1007/s13277-013-1145-9 | 0.117 | |||
| 2019 | Wang G, Qin S, Zayas J, Ingle JN, Liu M, Weinshilboum RM, Shen K, Wang L. 4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion. Breast Cancer Research and Treatment. PMID 30937657 DOI: 10.1007/S10549-019-05194-Z | 0.116 | |||
| 2019 | Shao Z, Pang D, Yang H, Li W, Wang S, Cui S, Liao N, Wang Y, Wang C, Chang YC, Wang H, Kang SY, Seo JH, Shen K, Laohawiriyakamol S, et al. Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial. Jama Oncology. PMID 31647503 DOI: 10.1001/jamaoncol.2019.3692 | 0.116 | |||
| 2010 | Chen X, Ma C, Wu J, Yang W, Lu H, Wu J, Lu J, Shao Z, Shen Z, Shen K. Molecular Subtype Approximated by Quantitative Estrogen Receptor, Progesterone Receptor and Her2 Can Predict the Prognosis of Breast Cancer Tumori Journal. 96: 103-110. DOI: 10.1177/030089161009600117 | 0.116 | |||
| 2015 | Liang Y, Chen X, Wu J, Huang O, Zong Y, Mao Y, Li Y, Chen W, Zhu L, He J, Fang Q, Zhang N, Shen K. P0168 Role of multidisciplinary teams in breast cancer adjuvant therapy: An analysis of decision-making related factors European Journal of Cancer. 51: e32. DOI: 10.1016/j.ejca.2015.06.095 | 0.116 | |||
| 2017 | Hong J, Chen XS, Wu JY, Huang O, Zhu L, He JR, Fang Q, Chen WG, Li YF, Shen KW. [Analysis of the factors influencing adjuvant chemotherapy decisions for triple negative breast cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 39: 39-43. PMID 28104032 DOI: 10.3760/cma.j.issn.0253-3766.2017.01.008 | 0.116 | |||
| 2009 | Ma CD, Zhou Q, Nie XQ, Liu GY, Di GH, Wu J, Lu JS, Yang WT, Chen JY, Shao ZM, Shen KW, Shen ZZ. Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patterns. Critical Reviews in Oncology/Hematology. 71: 258-65. PMID 19150602 DOI: 10.1016/j.critrevonc.2008.11.005 | 0.116 | |||
| 2013 | Mao Y, Keller ET, Garfield DH, Shen K, Wang J. Stromal cells in tumor microenvironment and breast cancer Cancer and Metastasis Reviews. 32: 303-315. PMID 23114846 DOI: 10.1007/S10555-012-9415-3 | 0.116 | |||
| 2016 | Mao Y, Qu Q, Chen X, Huang O, Wu J, Shen K. The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis. Plos One. 11: e0152500. PMID 27073890 DOI: 10.1371/journal.pone.0152500 | 0.116 | |||
| 2020 | Wu J, Gao W, Chen X, Fei C, Lin L, Chen W, Huang O, Zhu S, He J, Li Y, Zhu L, Shen K. Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients. Frontiers of Medicine. PMID 33367943 DOI: 10.1007/s11684-020-0738-0 | 0.116 | |||
| 2020 | Ding S, Chen X, Shen K. Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy. Cancer Communications (London, England). PMID 32654419 DOI: 10.1002/cac2.12078 | 0.116 | |||
| 2017 | Zong Y, Wu J, Shen K. Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis. Oncotarget. PMID 28061451 DOI: 10.18632/oncotarget.14477 | 0.115 | |||
| 2008 | Yu KD, Di GH, Wu J, Lu JS, Shen KW, Liu GY, Shen ZZ, Shao ZM. Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment. Journal of Cancer Research and Clinical Oncology. 134: 1347-54. PMID 18488249 DOI: 10.1007/s00432-008-0414-2 | 0.115 | |||
| 2014 | Mao Y, Qu Q, Zhang Y, Liu J, Wang G, Liang Y, Shen K. The Prognosis of Signal Transducer and Activator of Transcription 3 Expression On Breast Cancer Survival: a Meta-Analysis and Retrospective Study Annals of Oncology. 25: i18. DOI: 10.1093/ANNONC/MDU066.22 | 0.115 | |||
| 2014 | Mao Y, Qu Q, Zhang Y, Liu J, Chen X, Shen K. The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. Plos One. 9: e115103. PMID 25501357 DOI: 10.1371/journal.pone.0115103 | 0.114 | |||
| 2009 | Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Research and Treatment. 117: 409-16. PMID 19153831 DOI: 10.1007/s10549-008-0303-z | 0.114 | |||
| 2013 | Jiang M, Huang O, Zhang X, Xie Z, Shen A, Liu H, Geng M, Shen K. Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9. Molecules (Basel, Switzerland). 18: 701-20. PMID 23299550 DOI: 10.3390/molecules18010701 | 0.114 | |||
| 2020 | Xu B, Sun T, Zhang Q, Zhang P, Yuan Z, Z Jiang, Wang X, Cui S, Teng Y, Hu XC, Yang J, Pan H, Tong Z, Li H, Yao Q, ... ... Shen K, et al. Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase 3 randomised controlled trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 33188874 DOI: 10.1016/j.annonc.2020.10.600 | 0.114 | |||
| 2017 | Liang Y, Chen X, Zhu Y, Wu J, Huang O, Zong Y, Zhu S, Gao W, He J, Zhu L, Chen W, Li Y, Shen K. Abstract P2-01-16: Comparison of axillary nodal status between different defined clinically node negative breast cancer: Is ACOSOG Z0011 criteria applicable to preoperative cytologically negative axilla? Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P2-01-16 | 0.114 | |||
| 2021 | Pei S, Huang M, Huang J, Zhu X, Wang H, Romano S, Deng X, Wang Y, Luo Y, Hao S, Xu J, Yu T, Zhu Q, Yuan J, Shen K, et al. BFAR coordinates TGFβ signaling to modulate Th9-mediated cancer immunotherapy. The Journal of Experimental Medicine. 218. PMID 33914044 DOI: 10.1084/jem.20202144 | 0.113 | |||
| 2021 | Sun X, Ding S, Lu S, Wang Z, Chen X, Shen K. Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast Cancer. Oncotargets and Therapy. 14: 3611-3624. PMID 34113127 DOI: 10.2147/OTT.S290426 | 0.113 | |||
| 2015 | Chen X, Zhu S, Fei X, Garfield DH, Wu J, Huang O, Li Y, Zhu L, He J, Chen W, Jin X, Shen K. Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients. Bmc Cancer. 15: 822. PMID 26514283 DOI: 10.1186/s12885-015-1853-1 | 0.113 | |||
| 2017 | Mao Y, Chen XS, Liang Y, Wu JY, Huang O, Zong Y, Fang Q, He JR, Zhu L, Chen WG, Li YF, Lin L, Fei XC, Shen KW. [Effect of 21-gene recurrence score on chemotherapy decisions for patients with estrogen receptor-positive, epidermal growth factor receptor 2-negative and lymph node-negative early stage-breast cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 39: 502-508. PMID 28728295 DOI: 10.3760/cma.j.issn.0253-3766.2017.07.005 | 0.113 | |||
| 2014 | Qu Q, Zong Y, Fei XC, Chen XS, Xu C, Lou GY, Shen KW. The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast cancer. World Journal of Surgical Oncology. 12: 93. PMID 24721777 DOI: 10.1186/1477-7819-12-93 | 0.113 | |||
| 2021 | Yu J, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age. Journal of Translational Medicine. 19: 75. PMID 33593381 DOI: 10.1186/s12967-021-02743-3 | 0.112 | |||
| 2008 | Yu K, Di G, Wu J, Lu J, Shen K, Shen Z, Shao Z. Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumor: being younger and getting less benefit from adjuvant tamoxifen treatment European Journal of Cancer Supplements. 6: 182. DOI: 10.1016/S1359-6349(08)70759-6 | 0.112 | |||
| 2020 | Wang Z, Chen M, Pan J, Wang X, Chen XS, Shen KW. Pattern of distant metastases in inflammatory breast cancer - A large-cohort retrospective study. Journal of Cancer. 11: 292-300. PMID 31897225 DOI: 10.7150/jca.34572 | 0.111 | |||
| 2017 | Tong Y, Chen X, Fei X, Lin L, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Shen K. Can breast cancer patients with HER2 dual-equivocal tumours be managed as HER2-negative disease? European Journal of Cancer (Oxford, England : 1990). 89: 9-18. PMID 29223481 DOI: 10.1016/j.ejca.2017.10.033 | 0.11 | |||
| 2009 | Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, et al. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives Breast Cancer Research and Treatment. 114: 457-462. PMID 18446436 DOI: 10.1007/s10549-008-0036-z | 0.11 | |||
| 2008 | Liu GY, Lu JS, Shen KW, Wu J, Chen CM, Hu Z, Shen ZZ, Zhang TQ, Shao ZM. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge. Breast Cancer Research and Treatment. 108: 271-7. PMID 17473979 DOI: 10.1007/s10549-007-9598-4 | 0.109 | |||
| 2017 | Wu JY, Fang Y, Lin L, Zong Y, Chen XS, Huang O, He JR, Zhu L, Chen WG, Li YF, Shen KW. [Clinical utility study of 21-gene assay in 927 Chinese patients with early breast cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 39: 668-675. PMID 28926895 DOI: 10.3760/cma.j.issn.0253-3766.2017.09.006 | 0.109 | |||
| 2017 | Wang Q, Shen K, Logan AWJ, Colell JFP, Bae J, Ortiz GX, Theis T, Warren WS, Malcolmson SJ. Diazirines as Potential Molecular Imaging Tags: Probing the Requirements for Efficient and Long-Lived SABRE-Induced Hyperpolarization. Angewandte Chemie (International Ed. in English). PMID 28664640 DOI: 10.1002/Anie.201704970 | 0.109 | |||
| 2016 | Huang J, Chen X, Shen K, Li Y, Chen W, He J, Zhu L, Huang O, Zong Y, Fei X, Jin X. Abstract P3-01-13: Risk factors of non-sentinel lymph node metastasis in breast cancer patients with metastatic sentinel lymph node Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P3-01-13 | 0.109 | |||
| 2003 | Zhang J, Shen KW, Liu G, Zhou J, Shen Q, Shen ZZ, Shao ZM. Antigenic profiles of disseminated breast tumour cells and microenvironment in bone marrow. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 29: 121-6. PMID 12633553 DOI: 10.1053/ejso.2002.1334 | 0.108 | |||
| 2014 | Qu Q, Zhang Y, Liu J, Shen K. Tumor infiltrating lymphocytes (TIL) to predict response to neoadjuvant chemotherapy in breast cancer: A systemic review and meta-analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 138. PMID 28141028 DOI: 10.1200/jco.2014.32.26_suppl.138 | 0.108 | |||
| 2019 | Tong YW, Wang G, Wu JY, Huang O, He JR, Zhu L, Chen WG, Li YF, Chen XS, Shen KW. Insulin-like growth factor-1, metabolic abnormalities, and pathological complete remission rate in HER2-positive breast cancer patients receiving neoadjuvant therapy. Oncotargets and Therapy. 12: 3977-3989. PMID 31190894 DOI: 10.2147/OTT.S194981 | 0.108 | |||
| 2016 | Zhang Q, Shao Z, Shen K, Li L, Feng J, Tong Z, Gu K, Wang X, Xu B, Sun G, Chen H, Rukazenkov Y, Jiang Z. Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in China. Oncotarget. PMID 27359058 DOI: 10.18632/oncotarget.10254 | 0.108 | |||
| 2019 | Wang H, Zhan W, Chen W, Li Y, Chen X, Shen K. Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer. Breast (Edinburgh, Scotland). 49: 33-40. PMID 31677531 DOI: 10.1016/j.breast.2019.10.006 | 0.107 | |||
| 2004 | Lamichhane N, Shen KW, Li CL, Han QX, Zhang YJ, Shao ZM, Shen ZZ. Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid. Postgraduate Medical Journal. 80: 546-50. PMID 15356357 DOI: 10.1136/pgmj.2003.016311 | 0.107 | |||
| 2020 | Lin C, Wu J, Lin L, Fei X, Chen X, Huang O, He J, Chen W, Li Y, Shen K, Zhu L. A Novel Prognostic Scoring System Integrating Gene Expressions and Clinicopathological Characteristics to Predict Very Early Relapse in Node-Negative Estrogen Receptor-Positive/HER2-Negative Breast Cancer. Frontiers in Oncology. 10: 1335. PMID 33042787 DOI: 10.3389/fonc.2020.01335 | 0.106 | |||
| 2021 | Dong S, Wang Z, Shen K, Chen X. Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis. Frontiers in Oncology. 11: 629666. PMID 33842335 DOI: 10.3389/fonc.2021.629666 | 0.106 | |||
| 2020 | Zhu S, Chen X, Shen K. ASO Author Reflections: Core Needle Biopsy and Hormonal Receptor Retesting in Breast Cancer: Controversy and Management. Annals of Surgical Oncology. PMID 32661856 DOI: 10.1245/s10434-019-07961-0 | 0.106 | |||
| 2020 | Wu J, Ding S, Lin L, Fei X, Lin C, Andriani L, Goh C, Huang J, Hong J, Gao W, Zhu S, Wang H, Huang O, Chen X, He J, ... ... Shen K, et al. Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 32019280 DOI: 10.4143/crt.2019.387 | 0.106 | |||
| 2009 | Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, et al. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives Breast Cancer Research and Treatment. 115: 51-55. PMID 18483852 DOI: 10.1007/s10549-008-0052-z | 0.105 | |||
| 2019 | Jin ZY, Lu YJ, Chen WG, Li YF, Chen XS, Shen KW. [Factor analysis of diagnosis and surgical treatment of local regional recurrence in breast cancer patients]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 57: 366-372. PMID 31091592 DOI: 10.3760/cma.j.issn.0529-5815.2019.05.009 | 0.105 | |||
| 2021 | Sun X, Wang Z, Chen X, Shen K. CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer. Frontiers in Cell and Developmental Biology. 9: 646774. PMID 33816496 DOI: 10.3389/fcell.2021.646774 | 0.104 | |||
| 2007 | Yin W, Lu J, Liu G, Di G, Wu J, Shen K, Shen Z, Shao Z. P162 Time distribution of mortality risk for breast cancer and its clinical application The Breast. 16: S59. DOI: 10.1016/S0960-9776(07)70222-9 | 0.104 | |||
| 2007 | Yu KD, Liu GY, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients. Breast (Edinburgh, Scotland). 16: 307-15. PMID 17293115 DOI: 10.1016/j.breast.2006.12.011 | 0.104 | |||
| 2010 | Chen XS, Ma CD, Wu JY, Yang WT, Lu HF, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW. Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer. Tumori. 96: 103-10. PMID 20437866 | 0.103 | |||
| 2014 | Sun X, Mao Y, Wang J, Zu L, Hao M, Cheng G, Qu Q, Cui D, Keller ET, Chen X, Shen K, Wang J. IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer. Oncogene. PMID 24909173 DOI: 10.1038/onc.2014.158 | 0.103 | |||
| 2020 | Lu Y, Tong Y, Huang J, Lin L, Wu J, Fei X, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer Patients. Frontiers in Oncology. 10: 1315. PMID 32850415 DOI: 10.3389/fonc.2020.01315 | 0.102 | |||
| 2021 | Yu J, Lin C, Huang J, Hong J, Gao W, Zhu S, Lin L, Chen X, Huang O, He J, Zhu L, Chen W, Li Y, Wu J, Shen K. Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer Bmc Cancer. 21. DOI: 10.1186/s12885-021-08461-9 | 0.101 | |||
| 2020 | Wang Z, Wang H, Sun X, Fang Y, Lu SS, Ding SN, Chen XS, Shen KW. A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With Distant Metastasis. Frontiers in Oncology. 10: 14. PMID 32038988 DOI: 10.3389/fonc.2020.00014 | 0.101 | |||
| 2019 | Luo B, Yao Y, Tian E, Shen K, Song H, Song H, Li B. Interfacial Bonding and Electronic Structure between Copper Thiocyanate and Hybrid Organohalide Lead Perovskites for Photovoltaic Application. The Journal of Physical Chemistry Letters. PMID 31486649 DOI: 10.1021/acs.jpclett.9b02101 | 0.1 | |||
| 2017 | Zhu SJ, Chen XS, Wu JY, Huang O, He JR, Zhu L, Chen WG, Li YF, Fei XC, Shen KW. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 55: 114-119. PMID 28162210 DOI: 10.3760/cma.j.issn.0529-5815.2017.02.008 | 0.1 | |||
| 2016 | Fang Y, Wu J, Wang W, Fei X, Zong Y, Chen X, Huang O, He J, Chen W, Li Y, Shen K, Zhu L. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion. Oncotarget. PMID 27577080 DOI: 10.18632/Oncotarget.11639 | 0.1 | |||
| 2018 | Fang Q, Gan L, Chen YY, Shen KW, Wu BW. Percent Body Fat Change in Chinese Women After Adjuvant Chemotherapy for Breast Cancer. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 24: 5988-5995. PMID 30152448 DOI: 10.12659/MSM.911423 | 0.097 | |||
| 2015 | Huang O, Jiang M, Chen XS, Wu JY, Chen WG, Li YF, Shen KW. Prognostic factors of survival in pathologic incomplete response patients with locally advanced breast cancer after neoadjuvant chemotherapy. Cell Biochemistry and Biophysics. 71: 1181-90. PMID 25427887 DOI: 10.1007/s12013-014-0327-4 | 0.094 | |||
| 2019 | Tong Y, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. 21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph Nodes. Scientific Reports. 9: 13123. PMID 31511599 DOI: 10.1038/s41598-019-49644-6 | 0.094 | |||
| 2018 | Cao L, G Adedjouma N, Xu C, Shen KW, Laki F, Chen JY, Kirova YM. The role of post-mastectomy radiotherapy in elderly patients with 1-3 positive lymph nodes breast cancer: An International Retrospective Double-Center Study. The Breast Journal. PMID 30521123 DOI: 10.1111/tbj.13163 | 0.092 | |||
| 2019 | Liang Y, Chen X, Tong Y, Zhan W, Zhu Y, Wu J, Huang O, He J, Zhu L, Li Y, Chen W, Shen K. Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era. World Journal of Surgical Oncology. 17: 37. PMID 30786903 DOI: 10.1186/s12957-019-1582-z | 0.092 | |||
| 2020 | Yu J, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. Clinicopathological characteristics, adjuvant chemotherapy decision and disease outcome in patients with breast cancer with a 21-gene recurrence score of 26-30. Oncology Letters. 20: 1545-1556. PMID 32724396 DOI: 10.3892/ol.2020.11734 | 0.091 | |||
| 2015 | Liu J, Chen X, Ward T, Mao Y, Bockhorn J, Liu X, Wang G, Pegram M, Shen K. Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer. The International Journal of Biochemistry & Cell Biology. PMID 26643609 DOI: 10.1016/J.Biocel.2015.11.014 | 0.091 | |||
| 2014 | Wu JY, Chen WG, Chen XS, Huang O, He JR, Zhu L, Li Y, Shen KW. Long-term outcomes following adjuvant endocrine therapy in breast cancer patients with a positive-to-negative change of hormone receptor status following neoadjuvant chemotherapy. Molecular and Clinical Oncology. 2: 997-1002. PMID 25279188 DOI: 10.3892/mco.2014.365 | 0.09 | |||
| 2015 | Huang O, Wu D, Xie F, Lin L, Wang X, Jiang M, Li Y, Chen W, Shen K, Hu X. Targeting rho guanine nucleotide exchange factor ARHGEF5/TIM with auto-inhibitory peptides in human breast cancer. Amino Acids. 47: 1239-46. PMID 25743165 DOI: 10.1007/s00726-015-1950-0 | 0.089 | |||
| 2017 | Qu F, Wu J, Chen X, Huang O, He J, Zhu L, Chen W, Li Y, Shen K. Analysis of factors related to adjuvant chemotherapy decision in early breast cancer patients with intermediate recurrence score. Journal of Clinical Oncology. 35: e12032-e12032. DOI: 10.1200/JCO.2017.35.15_SUPPL.E12032 | 0.088 | |||
| 2020 | Zhu Y, Wang T, Wu J, Huang O, Zhu L, He J, Li Y, Chen W, Chen X, Shen K. Biomarkers of Insulin and the Insulin-Like Growth Factor Axis in Relation to Breast Cancer Risk in Chinese Women. Oncotargets and Therapy. 13: 8027-8036. PMID 32848423 DOI: 10.2147/OTT.S258357 | 0.088 | |||
| 2012 | Hao M, Zheng J, Hou K, Wang J, Chen X, Lu X, Bo J, Xu C, Shen K, Wang J. Role of chemokine receptor CXCR7 in bladder cancer progression. Biochemical Pharmacology. 84: 204-14. PMID 22525723 DOI: 10.1016/j.bcp.2012.04.007 | 0.086 | |||
| 2022 | Ye Z, Shi B, Huang Y, Ma T, Xiang Z, Hu B, Kuang Z, Huang M, Lin X, Tian Z, Deng Z, Shen K, Liu T. Revolution of vitamin E production by starting from microbial fermented farnesene to isophytol. Innovation (New York, N.Y.). 3: 100228. PMID 35373168 DOI: 10.1016/j.xinn.2022.100228 | 0.086 | |||
| 2014 | Zhang H, Li H, Song W, Shen D, Skanchy D, Shen K, Lionberger RA, Rosencrance SM, Yu LX. Completeness assessment of type II active pharmaceutical ingredient drug master files under generic drug user fee amendment: review metrics and common incomplete items. The Aaps Journal. 16: 1132-41. PMID 25034968 DOI: 10.1208/s12248-014-9630-7 | 0.085 | |||
| 2007 | Yin W, Lu J, Liu G, Di G, Wu J, Shen K, Shen Z, Shao Z. The rule of mortality risk in young women (≤35 years) with primary breast cancer Journal of Clinical Oncology. 25: 21098-21098. DOI: 10.1200/jco.2007.25.18_suppl.21098 | 0.085 | |||
| 2018 | Fang Q, Tong YW, Wang G, Zhang N, Chen WG, Li YF, Shen KW, Wu BW, Chen XS. Neutrophil-to-lymphocyte ratio, obesity, and breast cancer risk in Chinese population. Medicine. 97: e11692. PMID 30045325 DOI: 10.1097/MD.0000000000011692 | 0.085 | |||
| 2019 | Zhong L, Shen K, Zhai S, Chen T, Tao Q, Chen L, Tao Y, Qiu L. Application of sedation-agitation scale in conscious sedation before bronchoscopy in children. Medicine. 98: e14035. PMID 30608457 DOI: 10.1097/MD.0000000000014035 | 0.085 | |||
| 2019 | Huang L, Wang X, Zhou L, Di L, Zheng H, Jiang Z, Wang Y, Song X, Feng J, Yu S, Liu Y, Zheng H, Shen K, Tong Z, Shao Z. Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. PMID 31838561 DOI: 10.1007/s00280-019-04000-3 | 0.084 | |||
| 2022 | Ye Z, Huang Y, Shi B, Xiang Z, Tian Z, Huang M, Wu L, Deng Z, Shen K, Liu T. Coupling cell growth and biochemical pathway induction in Saccharomyces cerevisiae for production of (+)-valencene and its chemical conversion to (+)-nootkatone. Metabolic Engineering. 72: 107-115. PMID 35296429 DOI: 10.1016/j.ymben.2022.03.005 | 0.083 | |||
| 2019 | Wang W, Lin L, Fei X, Hong J, Gao W, Zhu S, Wu J, Huang O, He J, Li Y, Zhu L, Chen W, Chen X, Shen K. 21-Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypes. Oncology Letters. 18: 4346-4356. PMID 31579428 DOI: 10.3892/Ol.2019.10766 | 0.079 | |||
| 2020 | Gao W, Zeng Y, Fei X, Chen X, Shen K. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis. Breast Cancer Research and Treatment. PMID 32740809 DOI: 10.1007/s10549-020-05842-9 | 0.077 | |||
| 2021 | Tong Y, Gao W, Wu J, Zhu S, Huang O, He J, Zhu L, Chen W, Li Y, Shen K, Chen X. Comprehensive Association Analysis of 21-Gene Recurrence Score and Obesity in Chinese Breast Cancer Patients. Frontiers in Oncology. 11: 619840. PMID 33842323 DOI: 10.3389/fonc.2021.619840 | 0.077 | |||
| 2014 | Huang O, Xie Z, Zhang W, Lou Y, Mao Y, Liu H, Jiang M, Shen K. A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine-resistant breast cancer cells. Oncology Reports. 32: 627-34. PMID 24919713 DOI: 10.3892/or.2014.3249 | 0.076 | |||
| 2007 | Zhou L, Yin W, Lu J, Shi D, Liu G, Di G, Wu J, Shen K, Lu H, Shen Z, Shao Z. A comparison of tumor characteristics between ER+/PR+ and ER+/PR- breast tumors in Chinese women Journal of Clinical Oncology. 25: 21097-21097. DOI: 10.1200/JCO.2007.25.18_SUPPL.21097 | 0.074 | |||
| 2019 | Zhu S, Wu J, Huang O, He J, Zhu L, Li Y, Chen W, Fei X, Chen X, Shen K. Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical Sample. Annals of Surgical Oncology. PMID 31144143 DOI: 10.1245/s10434-019-07480-y | 0.074 | |||
| 2019 | Kong L, Xu G, Liu X, Wang J, Tang Z, Cai YS, Shen K, Tao W, Zheng Y, Deng Z, Price NPJ, Chen W. Divergent Biosynthesis of C-Nucleoside Minimycin and Indigoidine in Bacteria. Iscience. 22: 430-440. PMID 31816530 DOI: 10.1016/J.Isci.2019.11.037 | 0.068 | |||
| 2014 | Jiang M, Huang O, Xie Z, Wu S, Zhang X, Shen A, Liu H, Chen X, Wu J, Lou Y, Mao Y, Sun K, Hu S, Geng M, Shen K. A novel long non-coding RNA-ARA: adriamycin resistance-associated. Biochemical Pharmacology. 87: 254-83. PMID 24184505 DOI: 10.1016/j.bcp.2013.10.020 | 0.066 | |||
| 2023 | Zhang Y, Zheng F, Wang F, Liu X, Xiang C, Fu S, Shen K, Liu G. The Expression of Two Distinct Sets of Glycolytic Enzymes Reveals Differential Effects of Glycolytic Reprogramming on Pancreatic Ductal Tumorigenesis in Mice. Biomedicines. 11. PMID 38001963 DOI: 10.3390/biomedicines11112962 | 0.065 | |||
| 2020 | Ding S, Zong Y, Lin C, Andriani L, Chen W, Liu D, Chen W, Li Y, Shen K, Wu J, Zhu L. Validation of the Prognostic Stage of American Joint Committee on Cancer Eighth Edition Staging Manual in Invasive Lobular Carcinoma Compared to Invasive Ductal Carcinoma and Proposal of a Novel Score System. Frontiers in Oncology. 10: 1471. PMID 33014784 DOI: 10.3389/fonc.2020.01471 | 0.064 | |||
| 2020 | Gao W, Lin L, Fei X, Chen X, Shen K. Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence Score. Journal of Cancer. 11: 2509-2517. PMID 32201521 DOI: 10.7150/jca.38976 | 0.064 | |||
| 2023 | Shen K, Qu M, Zhao P. The Roads to Haploid Embryogenesis. Plants (Basel, Switzerland). 12. PMID 36678955 DOI: 10.3390/plants12020243 | 0.062 | |||
| 2021 | Mo J, Liu F, Sun X, Huang H, Tan K, Zhao X, Li R, Jiang W, Sui Y, Chen X, Shen K, Zhang L, Ma J, Zhao K, Tang Y. Inhibition of the FACT complex targets aberrant hedgehog signaling and overcomes resistance to smoothened antagonists. Cancer Research. PMID 33853831 DOI: 10.1158/0008-5472.CAN-20-3186 | 0.062 | |||
| 2021 | Gong N, Shao K, Shen K, Gu Y, Liu Y, Ye J, Hu C, Shen L, Chen Y, Li D, Fan J. Chemical control of overwintering green algae to mitigate green tide in the Yellow Sea. Marine Pollution Bulletin. 168: 112424. PMID 33975157 DOI: 10.1016/j.marpolbul.2021.112424 | 0.06 | |||
| 2022 | Chen T, Wang Y, Zhang S, Gao Z, Zhao D, Wu J, Shen K, Sun B. Cathodic photoelectrochemical sensor developed for glutathione detection based on carrier transport in a TiCT/AgI heterojunction. Analytica Chimica Acta. 1233: 340487. PMID 36283778 DOI: 10.1016/j.aca.2022.340487 | 0.06 | |||
| 2017 | Wu YD, Zhang XL, Liu XH, Xu J, Zhang M, Shen K, Zhang SH, He YM, Ma Y, Zhang AH. The preparation, characterization, structure and dissolution analysis of apremilast solvatomorphs. Acta Crystallographica. Section C, Structural Chemistry. 73: 305-313. PMID 28378713 DOI: 10.1107/S2053229617002984 | 0.058 | |||
| 2009 | Rao NY, Hu Z, Li WF, Huang J, Ma ZL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, et al. Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients Breast Cancer Research and Treatment. 113: 467-477. PMID 18343994 DOI: 10.1007/s10549-008-9965-9 | 0.057 | |||
| 2017 | Liang Y, Chen X, Zhan W, Garfield DH, Wu J, Huang O, Li Y, Zhu L, Chen W, Shen K. Can Clinically Node-Negative Breast Cancer Patients with Suspicious Axillary Lymph Nodes at Ultrasound But Negative Fine-Needle Aspiration Be Approached as Having Node-Negative Disease? Annals of Surgical Oncology. PMID 28168389 DOI: 10.1245/s10434-017-5798-2 | 0.056 | |||
| 2015 | Sun K, Chai W, Fu C, Zhan Y, Shen K, Luo X, Yan F. Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging. European Radiology. PMID 26385807 DOI: 10.1007/s00330-015-4000-0 | 0.055 | |||
| 2009 | Ling H, Liu GY, Lu JS, Love S, Zhang JX, Xu XL, Xu WP, Shen KW, Shen ZZ, Shao ZM. Fiberoptic ductoscopy-guided intraductal biopsy improve the diagnosis of nipple discharge. The Breast Journal. 15: 168-75. PMID 19292803 DOI: 10.1111/j.1524-4741.2009.00692.x | 0.055 | |||
| 2020 | Zeng Y, Gao W, Chen X, Shen K. Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component. British Journal of Cancer. PMID 33335279 DOI: 10.1038/s41416-020-01212-w | 0.053 | |||
| 2021 | Luo M, Xu H, Dong Y, Shen K, Lu J, Yin Z, Qi M, Sun G, Tang L, Xiang J, Deng Z, Dickschat JS, Sun Y. The Mechanism of Dehydrating Bimodules in trans-Acyltransferase Polyketide Biosynthesis: A Showcase Study on Hepatoprotective Hangtaimycin. Angewandte Chemie (International Ed. in English). PMID 34219345 DOI: 10.1002/anie.202106250 | 0.051 | |||
| 2012 | Zheng J, Xiong D, Sun X, Wang J, Hao M, Ding T, Xiao G, Wang X, Mao Y, Fu Y, Shen K, Wang J. Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 5: 285-93. PMID 22528874 DOI: 10.1007/s12307-012-0103-1 | 0.05 | |||
| 2015 | Wu Y, Sun Y, Shen K, Sun S, Wang J, Jiang T, Cao S, Josiah SM, Pang J, Lin X, Liu B. Immediate Genetic and Epigenetic Changes in F1 Hybrids Parented by Species with Divergent Genomes in the Rice Genus (Oryza). Plos One. 10: e0132911. PMID 26208215 DOI: 10.1371/journal.pone.0132911 | 0.047 | |||
| 2020 | Shen K, Wang Y, Zhang J, Zong Y, Li G, Zhao C, Chen H. Revealing the effect of grain boundary segregation on Li ion transport in polycrystalline anti-perovskite LiClO: a phase field study. Physical Chemistry Chemical Physics : Pccp. PMID 31959999 DOI: 10.1039/c9cp06055c | 0.047 | |||
| 2014 | Shen K, Wagemaker M. Na(2+x)Ti6O13 as potential negative electrode material for Na-ion batteries. Inorganic Chemistry. 53: 8250-6. PMID 25079946 DOI: 10.1021/ic5004269 | 0.046 | |||
| 2008 | Quan CY, Wei H, Sun YX, Cheng SX, Shen K, Gu ZW, Zhang XZ, Zhuo RX. Polyethyleneimine modified biocompatible poly(N-isopropylacrylamide)-based nanogels for drug delivery. Journal of Nanoscience and Nanotechnology. 8: 2377-84. PMID 18572652 DOI: 10.1166/Jnn.2008.236 | 0.044 | |||
| 2015 | Wu Y, Sun Y, Wang X, Lin X, Sun S, Shen K, Wang J, Jiang T, Zhong S, Xu C, Liu B. Transcriptome shock in an interspecific F1 triploid hybrid of Oryza revealed by RNA sequencing. Journal of Integrative Plant Biology. PMID 25828709 DOI: 10.1111/jipb.12357 | 0.043 | |||
| 2020 | Zhou X, Liu Z, Shen K, Zhao P, Sun MX. Cell lineage-specific transcriptome analysis for interpreting cell fate specification of proembryos. Nature Communications. 11: 1366. PMID 32170064 DOI: 10.1038/s41467-020-15189-w | 0.042 | |||
| 2018 | Zong Y, Shen K, Sperinde J, Wallweber G, Huang W, Winslow JW, Liang W, Pegram MD. Quantitative measurement of total erbB2 (H2T), p110 t-erbB2, and erbB2:erbB3 (H23D) heterodimer expression and p110 t-erbB2 in malignant progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC). Journal of Clinical Oncology. 36: 12089-12089. DOI: 10.1200/JCO.2018.36.15_SUPPL.12089 | 0.041 | |||
| 2023 | Huang Y, Ye Z, Wan X, Yao G, Duan J, Liu J, Yao M, Sun X, Deng Z, Shen K, Jiang H, Liu T. Systematic Mining and Evaluation of the Sesquiterpene Skeletons as High Energy Aviation Fuel Molecules. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2300889. PMID 37271925 DOI: 10.1002/advs.202300889 | 0.039 | |||
| 2019 | Zhao P, Zhou X, Shen K, Liu Z, Cheng T, Liu D, Cheng Y, Peng X, Sun MX. Two-Step Maternal-to-Zygotic Transition with Two-Phase Parental Genome Contributions. Developmental Cell. PMID 31080059 DOI: 10.1016/j.devcel.2019.04.016 | 0.037 | |||
| 2021 | Luo Y, Li S, Shen K, Song Y, Zhang J, Su W, Yang X. Study on the Hemostasis Characteristics of Biomaterial Frustules Obtained from Diatom sp. Materials (Basel, Switzerland). 14. PMID 34279325 DOI: 10.3390/ma14133752 | 0.037 | |||
| 2019 | Goh CW, Wu J, Ding S, Lin C, Chen X, Huang O, Chen W, Li Y, Shen K, Zhu L. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes. Journal of Cancer Research and Clinical Oncology. PMID 31089799 DOI: 10.1007/s00432-019-02930-2 | 0.036 | |||
| 2021 | Wang L, Wang H, Shen K, Park H, Zhang T, Wu X, Hu M, Yuan H, Chen Y, Wu Z, Wang Q, Li Z. Development of Novel F-PET Agents for Tumor Hypoxia Imaging. Journal of Medicinal Chemistry. PMID 33901402 DOI: 10.1021/acs.jmedchem.0c01962 | 0.032 | |||
| 2020 | Lin LY, Peng CC, Chen KC, Wang HE, Wang CS, Shen KH, Peng RY. Manufacturing technology of banana-assorted breads: The fermentative characteristics affected by different banana cultivars. Food Science & Nutrition. 8: 2627-2641. PMID 32566180 DOI: 10.1002/fsn3.1539 | 0.032 | |||
| 2019 | Jiang M, Huang O, Xie Z, Wu S, Zhang X, Shen A, Liu H, Chen X, Wu J, Lou Y, Mao Y, Sun K, Hu S, Geng M, Shen K. Corrigendum to "A novel long non-coding RNA-ARA: Adriamycin resistance-associated" [Biochem. Pharmacol. 87 (2014) 254-283]. Biochemical Pharmacology. 172: 113732. PMID 31869579 DOI: 10.1016/j.bcp.2019.113732 | 0.031 | |||
| 2021 | He M, Zhong X, Li Z, Shen K, Zeng W. Progress in the treatment of knee osteoarthritis with high tibial osteotomy: a systematic review. Systematic Reviews. 10: 56. PMID 33583421 DOI: 10.1186/s13643-021-01601-z | 0.025 | |||
| 2013 | Gao K, Zhu XC, Yue LH, Feng J, Shen K. [Extracorporeal shock wave combined with functional training for the treatment of frozen shoulder]. Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology. 26: 401-3. PMID 23937033 | 0.02 | |||
| 2018 | Zhang N, Shen K, Yang X, Li Z, Zhou T, Zhang Y, Sheng Q, Zheng J. Simultaneous determination of arsenic, cadmium and lead in plant foods by ICP-MS combined with automated focused infrared ashing and cold trap. Food Chemistry. 264: 462-470. PMID 29853402 DOI: 10.1016/j.foodchem.2018.05.058 | 0.017 | |||
| 2019 | Yu T, Gan S, Zhu Q, Dai D, Li N, Wang H, Chen X, Hou D, Wang Y, Pan Q, Xu J, Zhang X, Liu J, Pei S, Peng C, ... ... Shen K, et al. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nature Communications. 10: 4353. PMID 31554795 DOI: 10.1038/S41467-019-12384-2 | 0.015 | |||
| 2014 | Xu G, Chen Y, Shen K, Wang X, Li F, He Y. The discovery of potentially selective human neuronal nitric oxide synthase (nNOS) Inhibitors: a combination of pharmacophore modelling, CoMFA, virtual screening and molecular docking studies. International Journal of Molecular Sciences. 15: 8553-69. PMID 24830557 DOI: 10.3390/ijms15058553 | 0.013 | |||
| 2005 | Chang XX, Dong BR, Shen K. [Study of beta-defensin-2 gene expression in the pulmonary tissue of the older rat stimulated by pneumococcal vaccine polyvalent]. Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition. 36: 824-6. PMID 16334563 | 0.013 | |||
| 2023 | Shen K, Yuan J, Li M, Wen X, Lu H. Measurement of the Acoustic Relaxation Absorption Spectrum of CO Using a Distributed Bragg Reflector Fiber Laser. Sensors (Basel, Switzerland). 23. PMID 37430652 DOI: 10.3390/s23104740 | 0.01 | |||
| 2020 | Zhu N, Cao J, Shen K, Chen X, Zhu S. A Decision Support System with Intelligent Recommendation for Multi-disciplinary Medical Treatment Acm Transactions On Multimedia Computing, Communications, and Applications. 16: 1-23. DOI: 10.1145/3352573 | 0.01 | |||
| Hide low-probability matches. | |||||